author-photo

Jose Alejandro Palacios-Fabrega

Astellas Pharma

9

Papers

163

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Intermittent micafungin for prophylaxis in a rat model of chronic Candida albicans gut colonization

2020 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (0)
TERRA regulate the transcriptional landscape of pluripotent cells through TRF1-dependent recruitment of PRC2

2019 eLife
Show All
- Source
- Cite
- Save
Citations (18)
Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study

2019 European Journal of Clinical Microbiology & Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (16)
Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Author response: TERRA regulate the transcriptional landscape of pluripotent cells through TRF1-dependent recruitment of PRC2

2019 eLife
Show All
- Source
- Cite
- Save
Citations (0)
1982. Multiplex PCR-Based Analysis of Enteric Pathogens in Faecal Samples from Patients with Clostridium difficile Infection in the Randomized, Controlled EXTEND Study Comparing the Efficacy of Extended-Pulsed Fidaxomicin With Vancomycin Therapy

2018 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND)

2018
Show All
- Source
- Cite
- Save
Citations (35)
1952. Evaluation of Relapse and Reinfection Using Whole-Genome Sequencing of Clostridium difficile Isolates From Elderly Patients With C. difficile Infection (CDI) in the EXTEND Randomized, Controlled, Comparative Study of Extended-Pulsed Fidaxomicin and Vancomycin for the Treatment of CDI

2018 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

2017 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (94)